| The Foundation is governed by its Board of Directors, currently: |
Professor Timothy Aitman DPhil FRCP
 Tim Aitman is Consultant Physician in the Imperial Academic Health Sciences Centre, Hammersmith Campus, Professor of Clinical and Molecular Genetics at the Imperial College London and Chair of the Section of Molecular Sciences at the MRC Clinical Sciences Centre. He is Strategic Theme Leader for Genetics in the Imperial College Faculty of Medicine and chairs the Imperial Molecular Pathology Group, which he co-founded with others at Imperial in 2008. Imperial Molecular Pathology won substantial funds from the National Institute of Health Research (NIHR) to equip and refurbish a Laboratory for Molecular Pathology Research, which opened in January 2011. He is a Fellow of the Royal College of Physicians and Academy of Medical Sciences, and a member of several external advisory boards including the Sir Jules Thorn Medical Advisory Committee and the editorial boards of Mammalian Genome, Physiological Genomics and BMC Bioinformatics. He was the Specialist Adviser for the House of Lords Science and Technology Committee's Inquiry into Genomic Medicine, and is currently a member of the Human Genetics Commission, the Government's advisory body on developments in Genetics.
|
Baroness Onora O'Neill CBE PBA
Formerly Principal of Newnham College, she is Professor of Philosophy at the University of Cambridge, President of the British Academy, and Chair of the Nuffield Foundation. She works mainly in ethics and political philosophy. She has been a member of the Nuffield Council on Bioethics and the Human Genetics Advisory Commission, and was closely involved in work on a number of reports on biomedical issues. She was created a life peer in 1999 (Baroness O’Neill of Bengarve), and sits as a crossbencher.
|
Ian Peacock
Ian Peacock is Chairman of Mothercare plc and is also Deputy Chairman of Lombard Risk Management plc. He is a Trustee of the WRVS and Chairman of the Financial Advisory Committee for Westminster Abbey. Ian was previously Chairman of Galiform PLC (formerly MFI Furniture Group) and has also held a number of senior positions in the banking industry in London, New York and Asia with Kleinwort Benson Group and with BZW. He was also a special adviser to the Bank of England from 1998 – 2000, and a non-executive director of Norwich and Peterborough Building Society until 2005
|
Sir Keith Peters FRS PMedSci
Sir Keith Peters is Emeritus Professor of Physic at the University of Cambridge, where he was Head of the School of Clinical Medicine and Honorary Consultant Physician at Addenbrooke's NHS Trust from 1987-2005. His research interests centre on the translation of basic medical science into clinical practice. He is a founding Fellow and President of the Academy of Medical Sciences and Fellow of the Royal Society. In March 2004 he was appointed to the Council of Science and Technology, of which he is currently co-Chairman. He is a Senior Consultant to GlaxoSmithKline and Chair of the Council of Cardiff University.
|
Professor Patrick Sissons MD FRCP FRCPath FMedSci
Patrick Sissons graduated from St. Mary’s Hospital, London, and undertook his postgraduate clinical and research training in nephrology and immunology in the Department of Medicine at the Royal Postgraduate Medical School (RPMS), in London. After four years as an NIH Fogarty Fellow at the Scripps Research Institute (La Jolla, Ca) where he acquired an interest in the immunology and pathogenesis of persistent virus infections, he returned to RPMS as a Wellcome Senior Lecturer, and then Professor of Infectious Disease.
In 1988 he moved to the Professorship of Medicine in the University of Cambridge, where with colleagues he established an academic Division of Infectious Disease in the Department of Medicine, developed the Infectious Disease Service and was Director of Medical Services in Cambridge University Hospitals. His group’s research focuses on the biology and pathogenesis of human cytomegalovirus infection (supported by an MRC programme held with his colleague John Sinclair), and he has served on numerous national grants committees and advisory bodies.
He became Regius Professor of Physic and Head of the School of Clinical Medicine in Cambridge in 2005, and Director of Cambridge University Health Partners, one of five formally designated Academic Health Science Centres in the UK, in 2009. He is Clinical Vice President of The Academy of Medical Sciences.
|
Dr Ron Zimmern MA FRCP FFPHM
Ron Zimmern trained as a doctor at Trinity College, Cambridge and the Middlesex Hospital, London. After specialising in neurology he obtained a law degree and entered public health medicine in 1983. Following seven years as Director of Public Health for Cambridge and Huntingdon Health Authority, he established the Public Health Genetics Unit in Cambridge in June 1997 with seed funding from the Cambridge health community. In 2002 he secured government funding for five years from the Genetics Knowledge Park programme to expand his team’s pioneering work in public health genomics.
Ron is Chairman of the Diagnostic and Screening Panel of the UK’s Health Technology Assessment programme, serves on the Genetics Commissioning Advisory Group and the Steering Group for the National Genetic Testing Network at the Department of Health, and is on the Council for the British Society of Human Genetics. He is also an Associate Lecturer and Director of the Institute of Public Health at the University of Cambridge.
Aside from public health genomics, Ron’s interests include strategic planning, the relationship between clinical services and teaching and research, priority setting in the NHS, and the law and ethics of medicine.
|
|
|